Glider PTCA Balloon Catheter Registry

Sponsor
TriReme Medical, LLC (Industry)
Overall Status
Completed
CT.gov ID
NCT01184352
Collaborator
(none)
125
6
26.1
20.8
0.8

Study Details

Study Description

Brief Summary

The objective of this Registry is to demonstrate the utility of the Glider PTCA Balloon Catheter for crossing during the treatment of coronary artery disease.

Condition or Disease Intervention/Treatment Phase
  • Device: TriReme Medical, Inc. Glider(TM) PTCA Balloon Catheter

Study Design

Study Type:
Observational
Actual Enrollment :
125 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Registry for PCI With the TriReme Medical, Inc. Glider(TM) PTCA Balloon Catheter
Study Start Date :
Jul 1, 2010
Actual Primary Completion Date :
Sep 1, 2012
Actual Study Completion Date :
Sep 1, 2012

Arms and Interventions

Arm Intervention/Treatment
PCI patients treated with Glider Device

Device: TriReme Medical, Inc. Glider(TM) PTCA Balloon Catheter
Percutaneous Coronary Interventions performed with the Glider PTCA Balloon Catheter

Outcome Measures

Primary Outcome Measures

  1. Technical Success [average of 1 hour]

    Percentage of lesions successfully crossed among those attempted with the Glider PTCA Balloon Catheter as assesed during procedure.

Secondary Outcome Measures

  1. Procedure Success [average of 2 days]

    Percentage of patients treated with at least one Glider PTCA Balloon Catheter having <50% residual diameter stenosis, or TIMI 3 flow if at a bifurcation side branch, without the development of in-hospital MACE (Major Adverse Cardiac Event).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing PCI who are at least 18 years old

  • PCI procedure included the use of at least one Glider PTCA Balloon Catheter

  • Patient has been informed, in accordance with local requirements, that their data will be used in the Glider Registry

Exclusion Criteria:
  • N/A

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vivantes Klinikum Zum Friedrichshain Berlin Germany
2 Klinikum Coburg Herzkatheterlabor Coburg Germany
3 Alfried Krupp Khs Essen Germany
4 Elisabeth-Krankenhaus Essen Kardiologie Essen Germany
5 University Klinikum Muenster Muenster Germany
6 Royal Brompton Hospital London United Kingdom

Sponsors and Collaborators

  • TriReme Medical, LLC

Investigators

  • Principal Investigator: Carlo DiMario, MD, Royal Brompton & Harefield NHS Foundation Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
TriReme Medical, LLC
ClinicalTrials.gov Identifier:
NCT01184352
Other Study ID Numbers:
  • CLR734
First Posted:
Aug 18, 2010
Last Update Posted:
Dec 6, 2012
Last Verified:
Dec 1, 2012
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 6, 2012